Literature DB >> 32016296

Another Targeted Therapy for ERBB2-Positive Breast Cancer.

Rebecca Voelker.   

Abstract

Entities:  

Year:  2020        PMID： 32016296     DOI： 10.1001/jama.2020.0222

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  2 in total

1.  MicroRNA-133a-3p suppresses malignant behavior of non-small cell lung cancer cells by negatively regulating ERBB2.

Authors:  Yanhui Xu; Lei Zhang; Lilong Xia; Xinhai Zhu
Journal:  Oncol Lett       Date:  2021-04-08       Impact factor: 2.967

2.  Expression of Nectin-4 in Bladder Urothelial Carcinoma, in Morphologic Variants, and Nonurothelial Histotypes.

Authors:  Jean H Hoffman-Censits; Kara A Lombardo; Vamsi Parimi; Sonia Kamanda; Woonyoung Choi; Noah M Hahn; David J McConkey; Bridget M McGuire; Trinity J Bivalacqua; Max Kates; Andres Matoso
Journal:  Appl Immunohistochem Mol Morphol       Date:  2021-09-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.